Quick Takeaways
- Arie Belldegrun has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $4,423,230.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Arie Belldegrun
- Location
- Los Angeles, CA
- Summary
- The estimated net worth of Arie Belldegrun is at least $4,423,230 dollars as of 04 Feb 2026. Arie Belldegrun is the Director of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $3.8M. Arie Belldegrun is the Director of Ginkgo Bioworks Holdings, Inc. and owns shares of Ginkgo Bioworks Holdings, Inc. (DNA) stock worth about $619.2K.
- Signature
- /s/Earl Douglas, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Arie Belldegrun and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Allogene Therapeutics, Inc. ($3,804,054).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Arie Belldegrun
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Director | $3,804,054 | 02 Feb 2026 | ||
| DNA, DNABW | Ginkgo Bioworks Holdings, Inc. | Director | $619,176 | 12 Jun 2024 | ||
| KRON | Kronos Bio, Inc. | Director | $0 | 20 Jun 2025 | ||
| URGN | UroGen Pharma Ltd. | Director | 26 Aug 2025 |
Insider Transactions Reported by Arie Belldegrun:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.